Clinical Cancer Drugs

Clinical Cancer Drugs

ISSN: 2212-697X
E-ISSN: 2212-6988

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.
The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.

Coverage	2014
Language	English
Journal Status	Active

Latest Articles Lasest articles RSS feed

- Neurotoxicity of Cisplatin as Monotherapy or Combined Chemotherapy in Cancer Treatment
  
  Authors: André N. Volpini, Igor José de Souza Marques and Iago D. L. Cavalcanti
- Differential Proliferative and Cytotoxic Effect of Selected Components of Essential Oils on Human Glioblastoma Cells
  
  Authors: Sumbla Sheikh, Alexander Sturzu, Hubert Kalbacher, Thomas Nägele, Ulrike Ernemann and Stefan Heckl

Most Cited Most Cited RSS feed

- Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
  
  Authors: Benny Johnson and Daruka Mahadevan
- Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
  
  Authors: Horacio Gonzalez, Carolina Lema, Robert A. Kirken, Rosa A. Maldonado, Armando Varela- Ramirez and Renato J. Aguilera
- Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
  
  Authors: Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter
- Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells
  
  Authors: Yahaira Santiago-Vázquez, Umashankar Das, Armando Varela-Ramirez, Sarah T. Baca, Yoshira Ayala-Marin, Carolina Lema, Swagatika Das, Alaa Baryyan, Jonathan R. Dimmock and Renato J. Aguilera
- Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
  
  Authors: Manon Launay, Joseph Ciccolini, Claire Fournel, Carmello Blanquicett, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
- Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
  
  Authors: G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken
- New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia
  
  By Tadeusz Robak
- Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer
  
  Authors: Manikanta Swamy Murahari and Mayur C. Yergeri
- The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo
  
  Authors: Paulina J. Villanueva, Denisse A Gutierrez, Lisett Contreras, Karla Parra, Aldo Segura-Cabrera, Armando Varela-Ramirez and Renato J Aguilera
- Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors
  
  Authors: Atasi De Chatterjee, Debarshi Roy, Priscilla Guevara, Rituraj Pal, Mahesh Narayan, Sukla Roychowdhury and Siddhartha Das
More Less

Clinical Cancer Drugs

Latest Articles Lasest articles RSS feed

Most Read This Month

Most Cited Most Cited RSS feed